IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 33 filers reported holding IMPEL NEUROPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,733 | -56.2% | 22,635 | +29.4% | 0.00% | – |
Q2 2023 | $22,217 | -12.0% | 17,493 | -3.0% | 0.00% | – |
Q1 2023 | $25,244 | -61.7% | 18,032 | +2.6% | 0.00% | – |
Q4 2022 | $65,888 | -87.4% | 17,570 | -83.6% | 0.00% | – |
Q3 2022 | $523,000 | -42.4% | 107,254 | +10.0% | 0.00% | – |
Q2 2022 | $908,000 | -58.8% | 97,471 | -71.8% | 0.00% | – |
Q1 2022 | $2,203,000 | -28.1% | 345,672 | -2.6% | 0.00% | – |
Q4 2021 | $3,064,000 | -6.4% | 355,077 | +32.1% | 0.00% | – |
Q3 2021 | $3,272,000 | +47.3% | 268,730 | +7.0% | 0.00% | – |
Q2 2021 | $2,222,000 | – | 251,063 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NVP Associates, LLC | 3,077,198 | $1,323,195 | 1.18% |
5AM Venture Management, LLC | 2,884,791 | $1,240,460 | 0.36% |
venBio Partners LLC | 2,759,791 | $1,186,710 | 0.34% |
Vivo Capital, LLC | 2,884,789 | $1,240,459 | 0.14% |
LASRY MARC | 225,874 | $97,126 | 0.10% |
Kohlberg Kravis Roberts & Co. L.P. | 4,135,971 | $1,778,468 | 0.06% |
DCF Advisers, LLC | 178,500 | $76,755 | 0.04% |
EPIQ PARTNERS, LLC | 16,325 | $7,020 | 0.01% |
MCDONALD PARTNERS LLC | 19,400 | $8,342 | 0.00% |
XTX Topco Ltd | 21,222 | $9,125 | 0.00% |